Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial

By afschroeder • December 13, 2025

Fergus KB, Ross KS, Scheuner MT, Blanco AM, Tice JA, Ziv E, Shieh Y, van 't Veer L, Olopade OI, Goodman DL, Tong BS, Harvey H, DeRosa D, Risty L, Silver E, Kaster A, Fiscalini AS, Blum K, Heise R, Sabacan L, Heditsian D, Brain S, Petruse A, Eklund M, Hiatt RA, Borowsky AD, Naeim A, Park HL, LaCroix AZ, Parker BA, Lancaster R, Esserman J, Wenger N, Arasu V, Anton-Culver H, Esserman LJ, Madlensky L. Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial. JAMA Intern Med. 2025 Dec 12:e257323. doi: 10.1001/jamainternmed.2025.7323. Epub ahead of print. PMID: 41385723; PMCID: PMC12701530.

Tags: General Internal Medicine, Hematology/Oncology, Publications

Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus in Two Southern California Counties

Pak K, Leng M, Nguyen J, Moussa K, Gish R, Han SH, Pockros P. Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus[...]

Endogenous sex hormones, sex hormone-binding globulin, and muscle health: insights into sarcopenia and sarcopenic obesity from the Women’s Health Initiative

Osmancevic A, Daka B, Larson JC, Allison M, Burney RO, Shadyab AH, Cauley JA, Crandall CJ. Endogenous sex hormones, sex hormone-binding globulin, and muscle health:[...]

Medicaid Coverage Restrictions and On-Label Buprenorphine Prescribing for Chronic Pain

Nguemeni Tiako MJ, Abrams MP, Pinto Taylor E. Medicaid Coverage Restrictions and On-Label Buprenorphine Prescribing for Chronic Pain. J Gen Intern Med. 2026 Feb 17.[...]